NEW HAVEN, CONN. & MANCHESTER, ENGLAND, June 30, 2021 - Bioasis Technologies Inc. (TSXV:BTI; OTCQB:BIOAF), (“Bioasis”) and Oxyrane UK Ltd (“Oxyrane”) are pleased to announce the initiation of a resea…

Gent, BELGIUM – Today Oxyrane announced the divestment of its Belgian operations as part of its transition towards a clinical stage company. As Oxyrane is finalising IND-enabling studies for its lead…

Gent, BELGIUM – July 15, 2018 – Oxyrane, a private biotechnology company developing novel enzyme replacement therapies, today announced the award of a grant from the Michael J. Fox Foundation. The gr…